- Research works
- 2 fractional, all time
- Citations
- 25 16.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Appili Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Appili Therapeutics (Canada) publish most on?
By volume in 2022–2025: Bacillus and Francisella bacterial research, Poxvirus research and outbreaks, SARS-CoV-2 and COVID-19 Research and Yersinia bacterium, plague, ectoparasites research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bacillus and Francisella bacterial research Molecular Biology 0 works
- 2 Poxvirus research and outbreaks Virology 0 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 4 Yersinia bacterium, plague, ectoparasites research Genetics 0 works
- 5 Fungal Infections and Studies Epidemiology 0 works
- 6 Antifungal resistance and susceptibility Infectious Diseases 0 works
- 7 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Appili Therapeutics (Canada)'s research output changed?
Other research institutions in Halifax
- Dalhousie University
- Saint Mary's University
- Mount Saint Vincent University
- Izaak Walton Killam Health Centre
- Technical University of Nova Scotia
- Queen Elizabeth II Health Sciences Centre
- Nova Scotia Department of Agriculture
- Nova Scotia Health Authority
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.